Hormonal therapies for acne

    March 2017 in “Clinics in Dermatology
    Brittany S. Barros, Diane Thiboutot
    Image of study
    TLDR Hormonal treatments can improve acne, but they come with potential side effects and risks.
    The document from March 1, 2017, reviews hormonal therapies for acne, highlighting the role of androgens in the condition and the potential presence of endocrinopathies like PCOS in some patients. It details treatment options such as androgen receptor blockers (e.g., spironolactone), adrenal androgen production blockers (e.g., glucocorticoids like prednisone), and ovarian androgen production blockers (e.g., GnRH agonists and oral contraceptives). A small study of 6 women showed improvement in acne with GnRH agonists over 6 months, while a multicenter study demonstrated significant acne improvement with a low-dose oral contraceptive pill in women aged 14-45 after three cycles. The document also discusses side effects and risks of these therapies, including the risk of breast cancer and hepatotoxicity with certain drugs, and the increased risk of thromboembolic events with OCPs, especially in women with higher BMI. It provides guidelines for physicians on endocrine workup and treatment options, and mentions potential future therapies under investigation at the time.
    View this study on sciencedirect.com →

    Cited in this study

    Related

      Treatment of hirsutism with the pure antiandrogen flutamide

      research Treatment of hirsutism with the pure antiandrogen flutamide

      130 citations ,   September 1990 in “Journal of the American Academy of Dermatology”
      Flutamide effectively reduced excessive hair growth and improved related symptoms in hirsutism patients without significant side effects.